A Dasatinib-Induced Chylothorax Persisting After the Discontinuation of Dasatinib

A Dasatinib-Induced Chylothorax Persisting After the Discontinuation of Dasatinib

Dasatanib is a second-generation tyrosine kinase inhibitor with activity on the BCR-ABL fusion gene. it is used in the treatment of BCR-ABL positive chronic myeloid leukaemia and has the known side effect of pleural effusion. This usually involves exudate with the presence of lymphocytes. A more com...

Full description

Bibliographic Details
Main Authors: Nicolas Bradt, Frederic Olbrechts, Patrick Alexander, Alexander Salembier
Format: Article
Language:English
Published: SMC MEDIA SRL 2022-10-01
Series:European Journal of Case Reports in Internal Medicine
Subjects:
dasatinib
chylothorax
chronic myeloid leukaemia
Online Access:https://www.ejcrim.com/index.php/EJCRIM/article/view/3601

Similar Items

Similar Items